The Global Story: Will the new cancer vaccine survive RFK Jr’s America?
Summary
This episode explores the breakthrough of a new mRNA-based personalized cancer vaccine and the political controversy surrounding the technology in the US. Host Asma Khalid speaks with science writer Tom Whipple about how mRNA, once a scientific dead end, was accelerated by the pandemic to save millions. They discuss the recent cancellation of $500 million in mRNA research funding by HHS Secretary RFK Jr., who questions the technology's safety and efficacy. The conversation highlights the tension between scientific promise and political skepticism, noting that while funding cuts may hinder U…
Topics discussed
Intro, ads, and episode overview on mRNA cancer vaccine
History of mRNA research and Nobel Prize winners
How the new personalized skin cancer vaccine works
Traditional vs. mRNA vaccines and Katalin Karikó's journey
Pandemic acceleration and the 'hype bubble' of mRNA
RFK Jr., vaccine skepticism, and funding cuts
Safety debates and the FDA's mRNA flu vaccine approval
Political impact, global security, and closing credits
Listen ad-free on Castria